ArticlePulmonary circulation2022

BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension.

Leslie A Spikes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.